Atlas Trials

Maintaining Suppression of Testosterone With Transdermal Estradiol Gel

Clinical trial NCT02349386 · TERMINATED

Trial details

NCT number
NCT02349386
Sponsor
BHR Pharma, LLC
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Cancer of the Prostate
Start date
2015-07-01
Primary completion
2017-06-14
Enrollment
34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.